Background NK cells express several specialized receptors through which they recognize and discriminate virally-infected/tumor cells efficiently from healthy cells and kill them. This ability to lyse is regulated by an array of inhibitory or activating receptors. The present study investigated the frequency of various NK receptors expressed by NK cell subsets from HIV-infected TB patients. The effect of IL-15+IL-12 stimulation on the expression of NK receptors was also studied. Methodology/Principal Findings The study included 15 individuals each from normal healthy subjects, pulmonary tuberculosis patients, HIV-infected individuals and patients with HIV and tuberculosis co-infection. The expression of NK cell receptors was analyzed on two NK cell subsets within the peripheral blood: CD16+CD3？ and CD56+CD3？ using flow cytometry. The expression of inhibitory receptors (CD158a, CD158b, KIRp70, CD85j and NKG2A) on NK subsets was increased in HIV, when compared to NHS. But the response in HIV-TB was not uniform. Stimulation with IL-15+IL-12 dropped (p<0.05) the expression of CD85j and NKG2A in HIV. The basal expression of natural cytotoxicity receptors (NKp30 and NKp46) on NK cell subsets was lowered (p<0.05) in HIV and HIV-TB as compared to NHS. However, the expression of NKp44 and NKG2D was elevated in HIV. Enhanced NKp46 and NKG2D expression was observed in HIV with IL-15+IL-12 stimulation. The coreceptor NKp80 was found to be expressed in higher numbers on NK subsets from HIV compared to NHS, which elevated with IL-15+IL-12 stimulation. The expression of NK receptors and response to stimulation was primarily on CD56+CD3？ subset. Conclusions/Significance IL-15+IL-12 has an immunomodulatory effect on NK cell subsets from HIV-infected individuals viz down-regulation of iNKRs, elevation of activatory receptors NKp46 and NKG2D, and induction of coreceptor NKp80. IL-15+IL-12 is not likely to be of value when co-infected with TB probably due to the influence of tuberculosis.
References
[1]
Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189.220
[2]
Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A (1998) Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 102: 223.231
[3]
Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies DH (2002) Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 20: 853.885
[4]
Moretta L, Moretta A (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. Embo J 23: 255.259
[5]
Moretta A, Bottino C, Vitale M, Pende D, Biassoni R (1996) Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14: 619.648
[6]
Radaev S, Sun PD (2003) Structure and function of natural killer cell surface receptors. Annu Rev Biophys Biomol Struct 32: 93.114
[7]
Ullum H, Gotzsche PC, Victor J, Dickmeiss E, Skinhoj P (1995) Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J Exp Med 182: 789.799
[8]
Ramana Rao PV, Rajasekaran S, Raja A (2008) Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection. AIDS Res Hum Retroviruses 24: 1435.1443
[9]
Fresno M, Kopf M, Rivas L (1997) Cytokines and infectious diseases. Immunol Today 18: 56.58
[10]
Linnemeyer PA (1995) Interleukin-2. STEP Perspect 7: 6.7
[11]
Ramana Rao PV, Rajasekaran S, Raja A (2010) Natural killer cell-mediated cytokine response among HIV-positive south Indians with pulmonary tuberculosis. J Interferon Cytokine Res 30: 33.42
[12]
Ramana Rao PV, Rajasekaran S, Raja A (2010) Natural killer cell-derived cytolytic molecules in HIV-associated pulmonary tuberculosis-Role of exogenous interleukins. J Clin Immunol: [In Press].
[13]
Stevenson M (2003) HIV-1 pathogenesis. Nat Med 9: 853.860
[14]
Lieberman J, Shankar P, Manjunath N, Andersson J (2001) Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98: 1667.1677
[15]
Cambiaggi A, Orengo AM, Meazza R, Sforzini S, Tazzari PL (1996) The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function. Blood 87: 2369.2375
[16]
Moretta L, Biassoni R, Bottino C, Mingari MC, Moretta A (2001) Immunobiology of human NK cells. Transplant Proc 33: 60.61
[17]
Vance RE, Raulet DH (1998) Toward a quantitative analysis of the repertoire of class I MHC-specific inhibitory receptors on natural killer cells. Curr Top Microbiol Immunol 230: 135.160
[18]
Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661.671
[19]
Mavilio D, Benjamin J, Daucher M, Lombardo G, Kottilil S (2003) Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A 100: 15011.15016
[20]
Kottilil S, Shin K, Planta M, McLaughlin M, Hallahan CW (2004) Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. J Infect Dis 189: 1193.1198
[21]
Parato KG, Kumar A, Badley AD, Sanchez-Dardon JL, Chambers KA (2002) Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. Aids 16: 1251.1256
[22]
Cauda R, Goletti D, Lucia MB, Tumbarello M, Rumi C (1994) Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions. Clin Immunol Immunopathol 70: 198.205
[23]
Ahmad R, Sindhu ST, Tran P, Toma E, Morisset R (2001) Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients. J Med Virol 65: 431.440
[24]
Mingari MC, Vitale C, Cantoni C, Bellomo R, Ponte M (1997) Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol 27: 1374.1380
[25]
Bertone S, Schiavetti F, Bellomo R, Vitale C, Ponte M (1999) Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol 29: 23.29
[26]
Biassoni R, Cantoni C, Pende D, Sivori S, Parolini S (2001) Human natural killer cell receptors and co-receptors. Immunol Rev 181: 203.214
[27]
Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R (1999) NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 189: 787.796
[28]
Biassoni R, Pessino A, Bottino C, Pende D, Moretta L (1999) The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur J Immunol 29: 1014.1020
[29]
Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R (1999) Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 190: 1505.1516
[30]
Mantegani P, Tambussi G, Galli L, Din CT, Lazzarin A (2010) Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset. Immunology 129: 220.233
[31]
De Maria A, Fogli M, Costa P, Murdaca G, Puppo F (2003) The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 33: 2410.2418
[32]
Andre P, Castriconi R, Espeli M, Anfossi N, Juarez T (2004) Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur J Immunol 34: 961.971
[33]
Bozzano F, Nasi M, Bertoncelli L, Nemes E, Prati F (2011) NK-cell phenotype at interruption underlies widely divergent duration of CD4+-guided antiretroviral treatment interruption. Int Immunol 23: 109.118
[34]
Fu GF, Hao S, Zhao JL, Xu XQ, Guo HX (2009) Changes in NK cell counts and receptor expressions and emergence of CD3(dim)/CD56+ cells in HIV-1 infected patients in China. Viral Immunol 22: 105.116
[35]
Vankayalapati R, Wizel B, Weis SE, Safi H, Lakey DL (2002) The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 168: 3451.3457
[36]
Bozzano F, Costa P, Passalacqua G, Dodi F, Ravera S (2009) Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. Int Immunol 21: 779.791
[37]
Esin S, Batoni G, Counoupas C, Stringaro A, Brancatisano FL (2008) Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria. Infect Immun 76: 1719.1727
[38]
Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S (2009) NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol 183: 2610.2621
[39]
Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138: 325.335
[40]
De Maria A, Fogli M, Mazza S, Basso M, Picciotto A (2007) Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol 37: 445.455
[41]
Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E (2003) Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A 100: 4120.4125
[42]
Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC (1997) Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 158: 3603.3609
[43]
De Maria A, Moretta L (2000) HLA-class I-specific inhibitory receptors in HIV-1 infection. Hum Immunol 61: 74.81
[44]
Lanier LL, Phillips JH (1996) Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 17: 86.91
[45]
Yokoyama WM (1998) HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one. Proc Natl Acad Sci U S A 95: 4791.4794
[46]
Mason D, Andre P, Bensussan A, Buckley C, Civin C (2002) CD antigens 2002. Blood 99: 3877.3880
[47]
Moretta A, Bottino C, Vitale M, Pende D, Cantoni C (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19: 197.223
[48]
Ostrowski SR, Ullum H, Pedersen BK, Gerstoft J, Katzenstein TL (2005) 2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy. Clin Exp Immunol 141: 526.533
